NEW YORK (GenomeWeb) – Epistem today announced the government of India has issued a three-year import license to the firm's Indian distribution partner, Xcelris Labs, for its molecular tuberculosis and antibiotic resistance test.

The test runs on Epistem's point-of-care Genedrive molecular diagnostics platform, described as a one-pound integrated, handheld, endpoint PCR system with a footprint similar to that of a laptop computer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.